SCHEMBL1287564

SCHEMBL1287564

CCOc1ccccc1S(=O)(=O)NCCCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.59
ALDH1A1 P00352 4/20 0.56
POLB P06746 1/20 0.54
LMNA P02545 1/20 0.52
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
TP53 P04637 1/20 0.50
GAA P10253 1/20 0.50
KDM4E B2RXH2 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
MAPK1 P28482 1/20 0.49
CYP2C19 P33261 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.47
BRD4 O60885 1/20 0.47
BRD2 P25440 1/20 0.47
BRD3 Q15059 1/20 0.47
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6419015 0.83 LMNA (0.71) ALDH1A1POLBLMNAKDM4ECYP3A4
SCHEMBL411204 0.79 TDP1 (0.74) TDP1ALDH1A1POLBKMT2AMEN1
SCHEMBL1287477 0.78 ALDH1A1 (0.68) ALDH1A1POLBKMT2AMEN1TP53
SCHEMBL8752443 0.74 ALDH1A1 (0.55) ALDH1A1POLBLMNAKMT2AMEN1
SCHEMBL6137377 0.74 HTR1A (0.49) ALDH1A1POLBLMNAKDM4ECYP1A2
SCHEMBL5675703 0.73 ALDH1A1 (0.51) ALDH1A1LMNAKMT2AMEN1GAA
SCHEMBL407477 0.73 ALDH1A1 (1.00) TDP1ALDH1A1POLBLMNATP53
SCHEMBL28028806 0.73 MEN1 (0.90) TDP1ALDH1A1POLBLMNAKMT2A
SCHEMBL4617734 0.73 ALDH1A1 (0.63) TDP1ALDH1A1POLBLMNAKMT2A
SCHEMBL1287370 0.72 ALDH1A1 (0.59) TDP1ALDH1A1POLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012047926-A2 SULFONAMIDE-CONTAINING COMPOUNDS THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2012-04-12 WO disclosed